Key result
Traditional drug therapy combined with an exercise program for hypertensive patients yielded an incremental cost-effectiveness ratio of +79.69 compared to traditional drug therapy alone.
Why the study?
The study was conducted to evaluate the cost-utility of traditional drug therapy compared to traditional drug therapy combined with an exercise program for hypertensive patients in real-life primary care from a health system perspective.
Does traditional drug therapy combined with an exercise program improve cost-utility and quality of life compared to traditional drug therapy alone in hypertensive adults?
Cohort (n=49)
Does traditional drug therapy combined with an exercise program improve cost-utility and quality of life compared to traditional drug therapy alone in hypertensive adults?
Effect estimate: ICER +79.69
Adding an exercise program to traditional drug therapy for hypertensive patients in primary care is cost-effective and may improve quality of life.
Adding exercise to drug therapy may yield QALY gains at modest added cost in primary-care hypertension; leaves open cost-utility confirmation in randomized trials.
Aim: The study aimed to conduct a cost-utility analysis of traditional drug therapy (TDT) provided for hypertensive patients at primary care in comparison to the protocol based on combination with an exercise program (TDT+E) in real-life conditions, adopting a health system perspective. Methods: Longitudinal study based on enrollment of 49 hypertensive adults distributed into two groups, for 12 months. Quality-adjusted life years were estimated using health-related quality of life. Direct health care costs were calculated including inputs and human resources in primary care from medical records. Sensitivity analysis was performed based on multivariate and probabilistic scenarios. Results: Incremental cost-effectiveness ratios of TDT+E in comparison to TDT were +79.69. Sensitivity analysis showed that TDT+E presented advantages considering uncertainties. Conclusion: Our findings show that exercise programs may improve quality of life and life expectancy among hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Araújo et al. (2022) conducted a cohort in hypertension (n=49). Traditional drug therapy with exercise program (TDT+E) vs. Traditional drug therapy (TDT) alone was evaluated on Incremental cost-effectiveness ratio (ICER) (ICER +79.69). Traditional drug therapy combined with an exercise program for hypertensive patients yielded an incremental cost-effectiveness ratio of +79.69 compared to traditional drug therapy alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: